InvestorsHub Logo
Followers 335
Posts 18989
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Thursday, 11/16/2017 11:19:49 AM

Thursday, November 16, 2017 11:19:49 AM

Post# of 1990
Planning to submit in coming weeks an FDA amended protocol with an amended statistical analysis plan design that specifically looks at long term survival benefit comparing the combination arm to the control arm

https://seekingalpha.com/article/4124246-argos-therapeutics-args-ceo-jeff-abbey-q3-2016-results-earnings-call-transcript?part=single

DONT LISTEN TO ME IM CANADIANNNNNNNN

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.